Impacto Públicocivic observatory
Portuguêspt-PTEnglishcurrent languageEspañoles-ES

PUBLIC CONTRACT · 2019

41033719 - Aq urgente medicamentos

Contract value
€42,120.01
Signed on
4 November 2019
Procedure
Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 6008724

PUBLISHED SUBJECT

GOSERELINA (ACETATO),3.6MG IMPL ,SERINGA Olaparib 150 mg Comp Osimertinib 80 mg Comp Vedolizumab 300 mg Pó conc sol inj Fr IV Adalimumab 40 mg/0.4 ml Sol inj Caneta 0.4 ml SC Adalimumab 80 mg/0,8ml caneta pré-cheia Venetoclax 100 mg Comp

Parties involved

Place of performance
Portugal, Setúbal, Setúbal
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
Abbvie Lda. · Tax ID 510229050
Awardee
ASTRAZENECA PRODUTOS FARMACEUTICOS, LDA. · Tax ID 502942240
Awardee
TAKEDA - FARMACEUTICA PORTUGAL, LDA · Tax ID 502801204

Values and timeline

Contract price
€42,120.01
Procedure base price
€42,120.01
Total effective price
Not reported on Portal BASE
Publication date
7 November 2019
Award date
4 November 2019
Signing date
4 November 2019
Performance period
10 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Award criterion
Preço ou custo
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL 111-B/2017 ) e DLR no 34/2008/M, de 14.08 (DLR n.º 6/2018/M)
Framework agreement
Not stated
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
4252300

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts